Metabolomics Uncovers Biomarkers for PCOS Diagnosis and Therapy – JMSACL
JMSACL (Journal of Mass Spectrometry and Advances in the Clinical Lab) shared a post on LinkedIn:
“Source: (Journal of ovarian research)
Study on PCOS via mass spectrometry metabolomics identified 49 serum metabolites, with 39 upregulated and 10 downregulated. Key findings include altered lipid and amino acid metabolism, revealing candidate biomarkers for diagnosis and therapy. Metabolic pathways affected include sphingolipid metabolism.”
Title: Mass spectrometry-based untargeted metabolomics study of polycystic ovary syndrome
Authors: Ömer Faruk Özer, Ayşe Zeynep İbrahimoğlu, Ayşe Zehra Gül, Metin Demirel, Seda Ateş, Havva Sevde Taha, Merve İbrahimoğlu, Şahabettin Selek
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 10, 2025, 13:12ESHRE 2026 Registration Now Open in London! – ESHRE
-
Dec 10, 2025, 01:16Laurent Moulin: Research Shows Stress Affects Women’s Hearts More Than Men’s
-
Dec 10, 2025, 01:12Last Chance to Join Reproductive Surgery Masterclass – British Fertility Society
-
Dec 10, 2025, 01:09Personalised Diagnosis Could Transform Care for Rare Pregnancy Tumours – Wellbeing of Women
-
Dec 10, 2025, 01:05Snehal Gupta: Key Players and Trends Shaping the Future of Healthcare
-
Dec 10, 2025, 01:01Addressing Antidepressant Controversies in Pregnancy – CAUSALab
-
Dec 10, 2025, 00:58Unraveling Interleukin-22’s Impact on Pregnancy Outcomes – Fertility and Sterility
-
Dec 9, 2025, 15:03Oral Contraceptive Pills Prior to Natural Frozen Embryo Transfer Cycles – Fertility and Sterility
-
Dec 9, 2025, 14:40Medicine Laureate Ardem Patapoutian Will Be Watching Nobel Week Dialogue Today – The Nobel Prize